Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 1998

View Archived Issues

Fujisawa: FY 1998 highlights

Pentoxifylline shows efficacy in treatment of pruritus in HIV-infected patients

Compounds for bone diseases, neuropathy discovered at Takeda

New protein farnesyltransferase inhibitors prepared by Zeneca

Company Profile: ImmPheron

Imutech and Harvard Medical School join forces for clotrimazole development

Steroidogenesis Inhibitors seeks Romanian approval to begin pediatric trial with Anticort

Novartis and Trega sign agreement for obesity and diabetes research

Inex: Q1 1998 highlights

Schering AG presents factor Xa/thrombin inhibitors

Protein tyrosine or serine/threonine kinase inhibitors in development at Novartis

Agents for tumors and tumor metastasis synthesized at Ishihara Sangyo

Pfizer reports AChE inhibitors with memory-enhancing effects

Integrilin launched in first market today

New topical corticosteroid available in U.S. for ophthalmic use

Muscarinic receptor ligands from AHP with potential in treating cognition disorders

MMP/TNF-alpha convertase inhibitors disclosed by Agouron

JTV-519, a novel cardioprotective agent, and propranolol protect myocardium following SAH

FDA approves ADCON-L

ECG and hemodynamic evaluation of dronedarone, a new antiarrhythmic agent

Alzheimer's disease treatment launched in U.K.

Emisphere Technologies begins phase II trial with oral heparin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...